VIEMED HEALTHCARE INC (VMD)
Health Care · Home Medical Equipment (HME) and Respiratory Care Services · NASDAQ
Viemed is a specialized provider of home-based respiratory care and chronic disease management that aims to lower healthcare costs by treating patients in their homes.
What VIEMED HEALTHCARE INC does
Viemed Healthcare is a provider of home medical equipment and post-acute healthcare services in the United States, specializing in respiratory and chronic care management. The company utilizes a technology-enabled, home-based clinical model where licensed respiratory therapists provide therapy, education, and monitoring to patients. Its offerings include home ventilation, oxygen therapy, sleep apnea management, and women's health products, alongside healthcare staffing services.
Recent developments
In its Q2 2026 earnings release, Viemed reported record quarterly revenue of $78.1 million and raised the low end of its full-year 2026 revenue guidance to a range of $314 million to $320 million. The company also narrowed its Adjusted EBITDA guidance range to $64 million–$68 million and lowered its net capital expenditure outlook.
From VIEMED HEALTHCARE INC's filing of 2026-08-03.
Themes: Home-based healthcare, Respiratory care, Chronic disease management, Aging population / Medicare demographic, Value-based healthcare, Sleep apnea / PAP therapy
Fundamentals
- Price$9.41 as of 2026-10-08 close
- Market cap$358M as of 2026-07-27 (share count; price 2026-10-08)
- 1-year return+37.0% 2025-10-08 close $6.87 → 2026-10-08 close $9.41
- P/E26.25 as of 2026-10-08
- Net margin+5.5% FY2025, SEC XBRL
- Gross margin+57.5% FY2025, SEC XBRL
- ROE+10.6% FY2025, SEC XBRL
- Debt / equity0.05 as of 2026-09-02
- Revenue growth (YoY)+25.2% as of 2026-09-02
- Revenue CAGR (3y)+24.9% SEC XBRL
- Beta0.39 as of 2026-09-02
- Last reported earnings2026-08-03 SEC EDGAR Form 8-K (Item 2.02)
How VMD compares in its sector
- price-to-earnings ratiomiddle range 185 covered Health Care peers, as of 2026-10-08
- net profit marginmiddle range 430 covered Health Care peers, as of 2026-09-02
- operating marginmiddle range 417 covered Health Care peers, as of 2026-09-02
- gross marginmiddle range 189 covered Health Care peers, as of 2026-09-02
- return on equitytop 25% 510 covered Health Care peers, as of 2026-09-02
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How VIEMED HEALTHCARE INC looks technically
VIEMED HEALTHCARE INC (VMD) is trading 1.0% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed below its 200-day average about 2 trading days ago — a "death cross", a bearish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 19, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30). It just made a new 20-day high, its first since 2026-08-07, pushing above its recent trading range. It is 25.4% below its highest point of the past year.
Trend
9
| Distance from the 200-day | it is trading 1.0% above its 200-day average, the long-term trend line — a longer-term uptrend | +1.1% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $9.23 | $9.23 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $9.31 | $9.31 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing high 20 calendar days ago — the swings before that are what the structure reading is measured on | 20 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that upward direction; the labelling fails if price closes below 9.39. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible upward five-wave sequence, in wave 4 (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 2 trading days ago — a "death cross", a bearish long-term signal | 2 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 1.0% above | +1.1% |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 19, below the 25 that marks a real trend) | 19.4 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 60, neither overbought (above 70) nor oversold (below 30) | 59.9 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($8.66 to $9.60) — its "stochastic" reading is 80 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 79.8 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 31 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $12.61 | $12.61 |
|---|---|---|
| From the 52-week high | it is 25.4% below its 52-week high (its highest price of the past year) | -25.4% |
| Above the 52-week low | it is 55.5% above its 52-week low (its lowest price of the past year) | +55.5% |
| Below the 52-week high | it is 25.4% below its highest point of the past year | 25.4% |
| Since a 20-day breakout | it just made a new 20-day high, its first since 2026-08-07, pushing above its recent trading range | 1 session |
| Since a 55-day breakout | it made a new 55-day low about 35 trading days ago | 35 sessions |
| All-time high | its highest closing price on record is $12.61 (set on 2026-07-13) | $12.61 |
| Given back of the 52-week move | over the past year its closes ranged ($6.26 to $12.33), and it has given back around half of its rise from last year’s low — 48% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $8.38 to $8.58. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 48.1% |
| From the all-time high | it is 25.4% below its all-time high | -25.4% |
| Nearest price level | it is sitting right on a resistance level at $9.41 — a price it turned at three times since 2024-10-24, most recently on 2026-08-26. Since 2024-10-08 it has 12 such levels below the current price and 3 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | 0.0% |
| All-time low | its lowest closing price on record is $1.68 (set on 2018-01-04) | $1.68 |
| Above the all-time low | it is 459.3% above its all-time low | +459.3% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are about average versus its own recent 6-month history | 32nd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.2487 between its high and its low — about 2.6% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.2487 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $8.62 and $9.43 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $8.62 – $9.03 – $9.43 |
| Typical daily range (% of price) | its price moves about 2.6% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.6% |
| Stretch from the 200-day average | it is trading 0.4 daily ranges above its 200-day average price (1.1% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 0.4 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.96× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
1
| Since a doji | today it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | today |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-10-08 0.2% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.2% |
|---|---|---|
| Open gap | it gapped 9.7% below the previous close 46 sessions ago and has not traded back through the level it left behind at 11.69 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | -9.7% |
| Gap filled | a 2.5% gap down opened on 2026-09-08 has been "filled" 8 sessions ago — price traded back through the level the gap left behind, and it took 14 sessions to close | 8 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 5 sessions in a row, a +3.63% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 5 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 6.0 percentage points (the stock gained 7.1% while the market gained 1.0%) | +6.0% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 26.3 percentage points (the stock lost 22.5% while the market gained 3.8%) | -26.3% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 21.0 percentage points (the stock lost 3.6% while the market gained 17.5%) | -21.0% |
| vs market, 12 months | over the past 12 months this stock beat the market by 22.0 percentage points (the stock gained 37.0% while the market gained 15.0%) | +22.0% |
Signal agreement
2
| Bullish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bullish state: trading above its 200-day average, a fresh 20-day high, MACD momentum is positive — these describe past price behaviour, not a forecast | 3 of 9 |
|---|---|---|
| Bearish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 3 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 2.9% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is thick, spanning 9.3% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | -2.9% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 2% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $9.62 — a volume-weighted average of daily closes over 188 sessions, not a true tick-by-tick VWAP. | -2.1% |
|---|---|---|
| Vs the average paid since it last reported | the price is 2% above the average price paid since it last reported on 2026-08-03 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $9.20 — a volume-weighted average of daily closes over 48 sessions, not a true tick-by-tick VWAP. | +2.3% |
Double bottom, bullish — broke out · entry $9.33 · 34 sessions in
Price levels it has turned at before
VMD last closed at $9.41 on 2026-10-08. Since 2024-10-08 it has turned at 12 prices below its last close and 3 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $9.41 | Resistance | at the last close | turned there three times · 2024-10-24 to 2026-08-26 |
| $9.00 | Support | 4.4% below the last close | turned there four times · 2024-12-02 to 2026-09-18 |
| $9.86 | Resistance | 4.7% above the last close | turned there three times · 2024-11-07 to 2026-04-17 |
| $10.10 | Resistance | 7.3% above the last close | turned there three times · 2026-03-16 to 2026-06-22 |
| $8.62 | Support | 8.4% below the last close | turned there four times · 2025-01-27 to 2026-09-24 |
| $8.42 | Support | 10.6% below the last close | turned there five times · 2024-11-05 to 2026-08-21 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes below $9.39.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
On past moves of this shape the leg has usually ended somewhere between $8.95 and $9.39 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
This reading has stood for 1 trading day, since 2026-10-08.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Near 200-day moving-average support · Trading above the 200-day moving average · Recent death cross (50-day crossed below 200-day) · Pulled back from the 12-month high · Broke out to a new 20-day high · trendless / choppy (low ADX) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (2.50 mean, 1=Strong Buy…5=Strong Sell) — 2 analysts
- Mean price target$12.50 range $11.00 – $14.00
Analyst estimates, as of 2026-10-07. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Key risks (from latest filing)
["High dependence on Medicare and other government reimbursement policies for revenue.","Intense competition from larger, better-capitalized healthcare and medical equipment providers.","Regulatory risks related to healthcare compliance, billing, and changing coverage criteria for medical equipment."]
What changed in the latest 10-Q
AI-assisted comparison of VMD's 10-Q filed 2026-05-05 against the prior one filed 2025-11-05.
Management's Discussion & Analysis (MD&A)
- Removed:
- Removed from newer filing (2026-05-05): reference to 'the Company's expectations about its acquisition of Lehan's Medical Equipment, such as contingent payments and the anticipated synergies and other benefits related thereto' in the Forward-Looking Statements section
- Notes:
- Both filings appear to be truncated at the same point ('By their nature, forward-looking statements involve numerous assumptions, inherent risks and uncertainties, both general and specific, including those identified under "'), limiting full comparison of the complete sections
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 180 days · read to 2026-10-040 buys · 6 sells ($347167) — 2 selling insiders
Most recent open-market transaction: 2026-06-25. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about VMD's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding VMD as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 6,456,172
- Reported value $73,600,361
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 4 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about VMD's institutional holders → See what each manager we track holds →
Short interest (FINRA)
VMD had 1,323,822 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
VMD had 3.48% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 5.24 days to cover at the same settlement.
- Reported short interest (shares) 1,323,822
- Short interest (% of shares outstanding) 3.48%
- Prior settlement (shares) 1,207,333
- Reported change 9.65%
- Days to cover (reported) 5.24
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Linde (LIN)
- Air Liquide (AIQUY)
- AdaptHealth (AHCO)
- LHC Group (UNH)
- Amedisys (AMED)
- Apria Healthcare
- ResMed (RMD)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare VMD vs…
VIEMED HEALTHCARE INC is found in…
Frequently asked questions
What does VIEMED HEALTHCARE INC (VMD) do?
Viemed Healthcare is a provider of home medical equipment and post-acute healthcare services in the United States, specializing in respiratory and chronic care management. The company utilizes a technology-enabled, home-based clinical model where licensed respiratory therapists provide therapy, education, and monitoring to patients. Its offerings include home ventilation, oxygen therapy, sleep apnea management, and women's health products, alongside healthcare staffing services.
What sector is VIEMED HEALTHCARE INC (VMD) in?
VIEMED HEALTHCARE INC (VMD) is classified in the Health Care sector. Its industry is Home Medical Equipment (HME) and Respiratory Care Services. It trades on NASDAQ.
Who are VIEMED HEALTHCARE INC's (VMD) competitors?
Notable peers of VIEMED HEALTHCARE INC (VMD) include Linde, Air Liquide, AdaptHealth, LHC Group and Amedisys. This peer set is informational only — not financial advice.
Is VIEMED HEALTHCARE INC (VMD) overbought or oversold right now?
VIEMED HEALTHCARE INC (VMD) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 60, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on VMD come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest; prices are market data, as of 2026-09-02; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.